RTO vs CNXC

For growth investors, Concentrix Corporation (CNXC) is the stronger pick with 2.

2% revenue growth year-over-year, versus -5. 5% for Rentokil Initial plc (RTO). Rentokil Initial plc (RTO) offers the better valuation at 35. 4x trailing P/E (31. 2x forward), making it the more compelling value choice. Analysts rate Rentokil Initial plc (RTO) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Concentrix Corporation is actually cheaper at 2.

1x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Rentokil Initial plc (RTO) delivered a total return of +5.

0%, compared to -80. 3% for Concentrix Corporation (CNXC). Over 10 years, the gap is even starker: RTO returned +195. 1% versus CNXC's -62. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Rentokil Initial plc (RTO) is the lower-risk stock at 0.

72β versus Concentrix Corporation's 1. 33β — meaning CNXC is approximately 84% more volatile than RTO relative to the S&P 500. On balance sheet safety, Rentokil Initial plc (RTO) carries a lower debt/equity ratio of 112% versus 169% for Concentrix Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Concentrix Corporation (CNXC) is pulling ahead at 2.

2% versus -5. 5% for Rentokil Initial plc (RTO). On earnings-per-share growth, the picture is similar: Rentokil Initial plc grew EPS 16. 7% year-over-year, compared to -648. 8% for Concentrix Corporation. Over a 3-year CAGR, CNXC leads at 15. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Rentokil Initial plc (RTO) is the more profitable company, earning 6.

8% net margin versus -13. 0% for Concentrix Corporation — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RTO leads at 13. 7% versus 6. 2% for CNXC. At the gross margin level — before operating expenses — CNXC leads at 35. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Concentrix Corporation (CNXC) trades at 2.

1x forward P/E versus 31. 2x for Rentokil Initial plc — 29. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CNXC: 104. 2% to $52. 00.

All stocks in this comparison pay dividends.

Concentrix Corporation (CNXC) offers the highest yield at 5. 6%, versus 1. 8% for Rentokil Initial plc (RTO).

For long-horizon retirement investors, Rentokil Initial plc (RTO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

72), 1. 8% yield, +195. 1% 10Y return). Both have compounded well over 10 years (RTO: +195. 1%, CNXC: -62. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (RTO (Industrials) and CNXC (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: RTO is a mid-cap quality compounder stock; CNXC is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.